<p>Establishment Labs Holdings Inc.（納斯達克代碼：ESTA - 獲取免費報告）在週五達到了新的 52 周高點。該公司交易價格最高為 72.43 美元，最後交易價格為 72.5050 美元，成交量為 68163 股。該股票此前收盤價為 70.71 美元。</p>
<p>獲取 <strong>Establishment Labs</strong> 的提醒：</p>
<h2>華爾街分析師觀點</h2>
<p>幾位股票研究分析師最近對該公司發表了看法。摩根大通將 Establishment Labs 的目標價格從 45.00 美元上調至 71.00 美元，並在 11 月 6 日的研究報告中給予該公司 “超配” 評級。瑞穗將 Establishment Labs 的目標價格從 70.00 美元上調至 85.00 美元，並在 11 月 6 日的研究報告中給予該公司 “跑贏大盤” 評級。BTIG 研究將 Establishment Labs 的目標價格從 70.00 美元上調至 81.00 美元，並在 11 月 14 日的研究報告中給予該股票 “買入” 評級。Wall Street Zen 在 10 月 19 日的報告中將 Establishment Labs 的評級從 “賣出” 上調至 “持有”。最後，花旗集團在 10 月 7 日的報告中重申了對 Establishment Labs 股票的 “中性” 評級。六位分析師給予該股票 “買入” 評級，一位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，Establishment Labs 的共識評級為 “適度買入”，共識目標價格為 68.29 美元。</p>
<p><strong>查看我們關於 Establishment Labs 的最新研究報告</strong></p>
<h2>Establishment Labs 價格表現</h2>
<p>該股票的 50 日移動平均線為 54.70 美元，200 日移動平均線為 44.96 美元。該股票的市值為 21 億美元，市盈率為-25.38，貝塔值為 1.01。該公司的流動比率為 3.33，速動比率為 2.10，債務股本比率為 15.06。</p>
<p>Establishment Labs（納斯達克代碼：ESTA - 獲取免費報告）最近在 11 月 5 日發佈了季度財報。該公司報告季度每股收益為（0.38 美元），超出分析師共識預期的（0.54 美元）0.16 美元。Establishment Labs 的股本回報率為負 235.45%，淨利潤率為負 43.45%。該公司季度收入為 5378 萬美元，而分析師預期為 5228 萬美元。在去年同期，該公司每股收益為（0.59 美元）。該公司的收入同比增長 33.8%。作為一個整體，股票研究分析師預測 Establishment Labs Holdings Inc.在本年度將發佈-2.41 美元的每股收益。</p>
<h2>機構投資者對 Establishment Labs 的看法</h2>
<p>幾家對沖基金和其他機構投資者最近增加或減少了對 ESTA 的持股。瑞士國家銀行在第一季度將其在 Establishment Labs 的持股增加了 1.3%。瑞士國家銀行目前擁有 39000 股該公司的股票，價值 159.1 萬美元，此前在上一季度購買了 500 股。Nuveen LLC 在第一季度獲得了 Establishment Labs 的新股份，價值約為 1305.4 萬美元。Tejara Capital Ltd 在第一季度購買了 Establishment Labs 的新股份，價值約為 229.4 萬美元。Raymond James Financial Inc.在第一季度將其在 Establishment Labs 的持股增加了 0.4%。Raymond James Financial Inc.目前擁有 119752 股該公司的股票，價值 488.6 萬美元，此前在上一季度購買了 491 股。最後，Nantahala Capital Management LLC 在第一季度將其在 Establishment Labs 的持股增加了 7.2%。Nantahala Capital Management LLC 目前擁有 1774044 股該公司的股票，價值 7239 萬美元，此前在上一季度購買了 119574 股。機構投資者和對沖基金持有該公司 72.91% 的股票。</p>
<h2>關於 Establishment Labs</h2>
<p>（獲取免費報告）</p>
<p>Establishment Labs Holdings Inc.是一家醫療技術公司，製造和銷售用於美容和重建整形外科的醫療設備。該公司主要提供 Motiva Implants 品牌的硅膠填充乳房植入物。它還提供 Motiva Ergonomix 和 Motiva Ergonomix2 重力敏感圓形軟硅膠填充乳房植入物；以及 Motiva Flora 組織擴張器，一種乳房組織擴張器。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更喜歡的五隻股票，而不是 Establishment Labs</li>
<li>什麼是國債？</li>
<li>Salesforce 股票像彈簧一樣蓄勢待發，準備反彈</li>
<li>什麼是支撐位？</li>
<li>Marvell 的反彈延續：數據中心和 AMZN 芯片推動股價</li>
<li>使用 MarketBeat 股息税計算器</li>
<li>Ross Stores 股票能否在聖誕節前達到 200 美元？分析師認為有三個理由支持這一觀點</li>
</ul>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Establishment Labs 嗎？</h2>
<p>在你考慮 Establishment Labs 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向他們的客户推薦，現在就買入，以便在更廣泛的市場注意到之前……而 Establishment Labs 並不在名單上。</p>
<p>雖然 Establishment Labs 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得買入。</p>
<p>查看這五隻股票</p>

ESTA

<p>Establishment Labs（納斯達克代碼：ESTA）達到了新的 52 周高點，交易價格高達 72.43 美元。分析師們提高了他們的目標價格，摩根大通將其上調至 71 美元，瑞穗則上調至 85 美元。該公司報告的收益超出預期，收入同比增長 33.8%。機構投資者表現出興趣，對沖基金持有顯著股份。Establishment Labs 專注於塑料手術的醫療設備，主要提供硅膠填充的乳房植入物</p>

<p>Establishment Labs Holdings Inc. (NASDAQ:ESTA - Get Free Report) reached a new 52-week high on Friday . The company traded as high as $72.43 and last traded at $72.5050, with a volume of 68163 shares changing hands. The stock had previously closed at $70.71.</p>
<div class="lb-trans"><p>Establishment Labs Holdings Inc.（納斯達克代碼：ESTA - 獲取免費報告）在週五達到了新的 52 周高點。該公司交易價格最高為 72.43 美元，最後交易價格為 72.5050 美元，成交量為 68163 股。該股票此前收盤價為 70.71 美元。</p>
</div><p>Get <strong>Establishment Labs</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Establishment Labs</strong> 的提醒：</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師觀點</h2>
</div><p>Several equities research analysts have recently weighed in on the company. JPMorgan Chase &amp; Co. upped their price objective on Establishment Labs from $45.00 to $71.00 and gave the company an &#34;overweight&#34; rating in a research note on Thursday, November 6th. Mizuho upped their price target on Establishment Labs from $70.00 to $85.00 and gave the company an &#34;outperform&#34; rating in a research report on Thursday, November 6th. BTIG Research increased their price objective on Establishment Labs from $70.00 to $81.00 and gave the stock a &#34;buy&#34; rating in a research note on Friday, November 14th. Wall Street Zen raised Establishment Labs from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Sunday, October 19th. Finally, Citigroup reaffirmed a &#34;neutral&#34; rating on shares of Establishment Labs in a report on Tuesday, October 7th. Six analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Establishment Labs has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $68.29.</p>
<div class="lb-trans"><p>幾位股票研究分析師最近對該公司發表了看法。摩根大通將 Establishment Labs 的目標價格從 45.00 美元上調至 71.00 美元，並在 11 月 6 日的研究報告中給予該公司 “超配” 評級。瑞穗將 Establishment Labs 的目標價格從 70.00 美元上調至 85.00 美元，並在 11 月 6 日的研究報告中給予該公司 “跑贏大盤” 評級。BTIG 研究將 Establishment Labs 的目標價格從 70.00 美元上調至 81.00 美元，並在 11 月 14 日的研究報告中給予該股票 “買入” 評級。Wall Street Zen 在 10 月 19 日的報告中將 Establishment Labs 的評級從 “賣出” 上調至 “持有”。最後，花旗集團在 10 月 7 日的報告中重申了對 Establishment Labs 股票的 “中性” 評級。六位分析師給予該股票 “買入” 評級，一位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat.com 的數據，Establishment Labs 的共識評級為 “適度買入”，共識目標價格為 68.29 美元。</p>
</div><p><strong>View Our Latest Research Report on Establishment Labs</strong></p>
<div class="lb-trans"><p><strong>查看我們關於 Establishment Labs 的最新研究報告</strong></p>
</div><h2>Establishment Labs Price Performance</h2>
<div class="lb-trans"><h2>Establishment Labs 價格表現</h2>
</div><p>The stock has a fifty day moving average of $54.70 and a two-hundred day moving average of $44.96. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of -25.38 and a beta of 1.01. The company has a current ratio of 3.33, a quick ratio of 2.10 and a debt-to-equity ratio of 15.06.</p>
<div class="lb-trans"><p>該股票的 50 日移動平均線為 54.70 美元，200 日移動平均線為 44.96 美元。該股票的市值為 21 億美元，市盈率為-25.38，貝塔值為 1.01。該公司的流動比率為 3.33，速動比率為 2.10，債務股本比率為 15.06。</p>
</div><p>Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The company reported ($0.38) EPS for the quarter, topping analysts' consensus estimates of ($0.54) by $0.16. Establishment Labs had a negative return on equity of 235.45% and a negative net margin of 43.45%.The company had revenue of $53.78 million for the quarter, compared to analyst estimates of $52.28 million. During the same quarter in the previous year, the firm earned ($0.59) earnings per share. The business's revenue was up 33.8% on a year-over-year basis. As a group, equities research analysts forecast that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.</p>
<div class="lb-trans"><p>Establishment Labs（納斯達克代碼：ESTA - 獲取免費報告）最近在 11 月 5 日發佈了季度財報。該公司報告季度每股收益為（0.38 美元），超出分析師共識預期的（0.54 美元）0.16 美元。Establishment Labs 的股本回報率為負 235.45%，淨利潤率為負 43.45%。該公司季度收入為 5378 萬美元，而分析師預期為 5228 萬美元。在去年同期，該公司每股收益為（0.59 美元）。該公司的收入同比增長 33.8%。作為一個整體，股票研究分析師預測 Establishment Labs Holdings Inc.在本年度將發佈-2.41 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Establishment Labs</h2>
<div class="lb-trans"><h2>機構投資者對 Establishment Labs 的看法</h2>
</div><p>Several hedge funds and other institutional investors have recently added to or reduced their stakes in ESTA. Swiss National Bank lifted its position in shares of Establishment Labs by 1.3% during the first quarter. Swiss National Bank now owns 39,000 shares of the company's stock worth $1,591,000 after purchasing an additional 500 shares in the last quarter. Nuveen LLC acquired a new stake in shares of Establishment Labs in the first quarter valued at approximately $13,054,000. Tejara Capital Ltd bought a new position in Establishment Labs in the 1st quarter worth approximately $2,294,000. Raymond James Financial Inc. lifted its holdings in Establishment Labs by 0.4% during the 1st quarter. Raymond James Financial Inc. now owns 119,752 shares of the company's stock worth $4,886,000 after buying an additional 491 shares in the last quarter. Finally, Nantahala Capital Management LLC boosted its position in Establishment Labs by 7.2% in the 1st quarter. Nantahala Capital Management LLC now owns 1,774,044 shares of the company's stock valued at $72,390,000 after buying an additional 119,574 shares during the last quarter. Institutional investors and hedge funds own 72.91% of the company's stock.</p>
<div class="lb-trans"><p>幾家對沖基金和其他機構投資者最近增加或減少了對 ESTA 的持股。瑞士國家銀行在第一季度將其在 Establishment Labs 的持股增加了 1.3%。瑞士國家銀行目前擁有 39000 股該公司的股票，價值 159.1 萬美元，此前在上一季度購買了 500 股。Nuveen LLC 在第一季度獲得了 Establishment Labs 的新股份，價值約為 1305.4 萬美元。Tejara Capital Ltd 在第一季度購買了 Establishment Labs 的新股份，價值約為 229.4 萬美元。Raymond James Financial Inc.在第一季度將其在 Establishment Labs 的持股增加了 0.4%。Raymond James Financial Inc.目前擁有 119752 股該公司的股票，價值 488.6 萬美元，此前在上一季度購買了 491 股。最後，Nantahala Capital Management LLC 在第一季度將其在 Establishment Labs 的持股增加了 7.2%。Nantahala Capital Management LLC 目前擁有 1774044 股該公司的股票，價值 7239 萬美元，此前在上一季度購買了 119574 股。機構投資者和對沖基金持有該公司 72.91% 的股票。</p>
</div><h2>About Establishment Labs</h2>
<div class="lb-trans"><h2>關於 Establishment Labs</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.</p>
<div class="lb-trans"><p>Establishment Labs Holdings Inc.是一家醫療技術公司，製造和銷售用於美容和重建整形外科的醫療設備。該公司主要提供 Motiva Implants 品牌的硅膠填充乳房植入物。它還提供 Motiva Ergonomix 和 Motiva Ergonomix2 重力敏感圓形軟硅膠填充乳房植入物；以及 Motiva Flora 組織擴張器，一種乳房組織擴張器。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Establishment Labs</li>
<li>What Are Treasury Bonds?</li>
<li>Salesforce Stock Is Coiled Like a Spring and Ready to Rebound</li>
<li>What is a support level?</li>
<li>Marvell's Rally Extends: Data Centers and AMZN Chips Boost Shares</li>
<li>Using the MarketBeat Dividend Tax Calculator</li>
<li>Could Ross Stores Stock Hit $200 by Christmas? Here Are 3 Reasons Analysts Think So</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更喜歡的五隻股票，而不是 Establishment Labs</li>
<li>什麼是國債？</li>
<li>Salesforce 股票像彈簧一樣蓄勢待發，準備反彈</li>
<li>什麼是支撐位？</li>
<li>Marvell 的反彈延續：數據中心和 AMZN 芯片推動股價</li>
<li>使用 MarketBeat 股息税計算器</li>
<li>Ross Stores 股票能否在聖誕節前達到 200 美元？分析師認為有三個理由支持這一觀點</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Establishment Labs Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Establishment Labs 嗎？</h2>
</div><p>Before you consider Establishment Labs, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Establishment Labs 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Establishment Labs wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向他們的客户推薦，現在就買入，以便在更廣泛的市場注意到之前……而 Establishment Labs 並不在名單上。</p>
</div><p>While Establishment Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Establishment Labs 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得買入。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Establishment Labs（納斯達克代碼：ESTA）創下新的 12 個月高點 - 以下是原因